Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today...

PT-112's mechanism of action promotes immunogenic cancer cell death through ribosomal biogenesis inhibition and organelle stress NEW YORK, Oct. 14, 2023 /PRNewswire/ -- Promontory Therapeutics...

Therap Services, the national leader in HIPAA-compliant electronic documentation solutions for organizations in the Long-Term Services and Supports (LTSS), Home and Community-Based Services...

Results from the Phase 3 studies evaluating impact of bimekizumab on pain and health-related quality of life in moderate-to-severe hidradenitis suppurativa will be shared in two oral presentations...

Hive Pro, a pioneer vendor in Threat Exposure Management today announced the highly-anticipated release of their new platform Uni5 Xposure, which debuts live at the GITEX GLOBAL trade show in...